Journal
ANNALS OF NEUROLOGY
Volume 68, Issue 1, Pages 102-107Publisher
WILEY
DOI: 10.1002/ana.21993
Keywords
-
Categories
Funding
- ALS Therapy Alliance
- Angel Fund
- Pierre L. de Bourgknecht ALS Research Foundation
- Al-Athel ALS Research Foundation
- ALS Family Charitable Foundation
- Packard Center for ALS Research
- American Academy of Neurology Foundation/ALS Association
- National Institute of Neurological Disorders and Stroke [IRO1NS050557-03]
- NIH National Institute of Environmental Health Sciences [RO1ES09883-04A2]
- Italian Ministry of Health [ex Art.56, n.533F/N1, RF2007/INN644440]
- Peviani family
Ask authors/readers for more resources
Three clustered, homologous paraoxonase genes (PON1, PON2, and PON3) have roles in preventing lipid oxidation and detoxifying organophosphates. Recent reports describe a genetic association between the PON genes and sporadic amyotrophic lateral sclerosis (ALS). We now report that in genomic DNA from individuals with familial and sporadic ALS, we have identified at least 7 PON gene mutations that are predicted to alter PON function. ANN NEUROL 2010;68:102-107
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
